KPC-2-IN-1
Modify Date: 2025-08-25 11:00:44
KPC-2-IN-1 structure
|
Common Name | KPC-2-IN-1 | ||
|---|---|---|---|---|
| CAS Number | 2232877-85-7 | Molecular Weight | 285.13 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C13H12BN3O2S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of KPC-2-IN-1KPC-2-IN-1, boronic acid derivative, is a potent KPC-2 inhibitor with Ki of 0.032 μM. KPC-2-IN-1 enhances the activity of cefotaxime in KPC-2 expressing E. coli. KPC-2-IN-1 exhibits well tolerated in human HEK-293 cells, which can be used for the study of E. coli resistance to β-lactam antibiotics[1][2]. |
| Name | KPC-2-IN-1 |
|---|
| Description | KPC-2-IN-1, boronic acid derivative, is a potent KPC-2 inhibitor with Ki of 0.032 μM. KPC-2-IN-1 enhances the activity of cefotaxime in KPC-2 expressing E. coli. KPC-2-IN-1 exhibits well tolerated in human HEK-293 cells, which can be used for the study of E. coli resistance to β-lactam antibiotics[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Ki: 0.032 μM (KPC-2)[1]. |
| In Vitro | KPC-2-IN-1 (compound 2e) (50 μg/mL; 16 h) enhances the activity of CTX or MEM in KPC-2 expressing E. coli and (5 μg/mL; 16 h) also shows good combination activity of increasing CTX or MEM susceptibility to E. coli NCTC 10418[1]. Cell Viability Assay[1] Cell Line: E. coli BL21 DE3 (KPC-2 producing) and NCTC 10418 Concentration: 5, 50 μg/mL (combine with cefotaxime (CTX) or meropenem (MEM)). Incubation Time: 16 h Result: Decreased the MIC of CTX (16 μg/mL) as well as MEM (>64 μg/mL) to ≤ 0.03 or ≤0.06 μg/mL (~512 to >1000-fold increase in susceptibility) againsted E. coli BL21 DE3 and NCTC 10418. |
| References |
| Molecular Formula | C13H12BN3O2S |
|---|---|
| Molecular Weight | 285.13 |